← back to search

Eik Vettorazzi

Universität Hamburg · DE
🔎 Find collaborators in Pathology and Forensic Medicine · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Multiple Sclerosis Research Studies, Cancer Immunotherapy and Biomarkers, Cardiac pacing and defibrillation studies, and Bone health and osteoporosis research.
h-index
47
citations
10,280
works
295
NIH funding
primary concept
Medicine
email

Recent publications

Circulating microRNA Profiles as Diagnostic Tools for High-Grade Cervical Lesions and HPV Genotype Stratification.
2026cited by 0position: contributordoi
Impact of clinical symptoms on quality of life in adult hypophosphatasia: a monocentric study in northern Germany.
2026cited by 0position: contributordoi
Liquid Biopsy Analysis of the EV-Associated Micro-RNA Signature in Vulvar Carcinoma May Benefit Disease Diagnosis and Prognosis.
2026cited by 0position: contributordoi
Interdisciplinary and Cross-Sectoral Perioperative Care Model in Cardiac Surgery: ERAS Implementation in the Setting of Minimally Invasive Heart Valve Surgery (INCREASE)-Results of a Randomized Controlled Trial.
2026cited by 0position: contributordoi
Rurality, travel distance, and effectiveness of remote patient management in patients with heart failure in the TIM-HF2 trial in Germany: a pre-specified analysis of an open-label, randomised controlled trial
The Lancet Regional Health - Europe 2025cited by 5position: middledoi
Efficacy of a mechanism-based psychological intervention for persistent gastrointestinal symptoms in ulcerative colitis and irritable bowel syndrome: results of a three-arm randomised controlled trial (SOMA.GUT-RCT)
eClinicalMedicine 2025cited by 2position: contributordoi
Rurality, travel distance, and effectiveness of remote patient management in patients with heart failure in the TIM-HF2 trial in Germany: a pre-specified analysis of an open-label, randomised controlled trial.
2025cited by 2position: contributordoi
Anogenital high-risk HPV prevalence and screening considerations in female transplant recipients: a cross-sectional study
BMC Women s Health 2025cited by 1position: middledoi
Redo surgical aortic valve replacement: An outdated technique in the era of valve-in-valve procedures?
2025cited by 1position: contributordoi
Mapping the Network of Persistent Somatic Symptoms Across Diseases: A Longitudinal Analysis from the SOMACROSS Research Unit
2025cited by 0position: contributordoi
Supplementary Figures 1 - 12, Supplementary Tables 1-5 from BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
2025cited by 0position: contributordoi
Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial.
2024cited by 26position: contributordoi
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer
European Urology 2024cited by 19position: middledoi
A Multimodal Lifestyle Psychosocial Survivorship Program in Young Cancer Survivors
JAMA Network Open 2024cited by 15position: middledoi
Impact of telemedical management on hospitalization and mortality in heart failure patients with diabetes: a post-hoc subgroup analysis of the TIM-HF2 trial
Cardiovascular Diabetology 2024cited by 9position: middledoi
Clinical effectiveness of patient-targeted feedback following depression screening in general practice (GET.FEEDBACK.GP): an investigator-initiated, prospective, multicentre, three-arm, observer-blinded, randomised controlled trial in Germany.
2024cited by 9position: contributordoi
Supplementary Figures 1 - 12, Supplementary Tables 1-5 from BLEACH&STAIN 15-marker multiplexed imaging in 3098 human carcinomas reveals 6 major PD-L1-driven immune phenotypes with distinct spatial orchestration
2024cited by 0position: contributordoi
Data from BLEACH&STAIN 15-marker multiplexed imaging in 3098 human carcinomas reveals 6 major PD-L1-driven immune phenotypes with distinct spatial orchestration
2024cited by 0position: contributordoi
Supplementary Figures 1 - 12, Supplementary Tables 1-5 from BLEACH&STAIN 15-marker multiplexed imaging in 3098 human carcinomas reveals 6 major PD-L1-driven immune phenotypes with distinct spatial orchestration
2024cited by 0position: contributordoi
Automated <scp>Ki</scp>‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry
The Journal of Pathology 2023cited by 32position: middledoi
Long-Term Antibody Response to SARS-CoV-2 in Children.
2023cited by 16position: contributordoi
Effect of adaptive servo-ventilation for central sleep apnoea in systolic heart failure on muscle sympathetic nerve activity: a SERVE-HF randomised ancillary study.
2023cited by 11position: contributordoi
BLEACH&amp;STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
Molecular Cancer Research 2023cited by 11position: middledoi
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial Orchestration.
2023cited by 9position: contributordoi
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry.
2023cited by 2position: contributordoi
Prospective controlled study on the effects of deep brain stimulation on driving in Parkinson's disease.
2023cited by 0position: contributordoi
Data from BLEACH&amp;STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
2023cited by 0position: contributordoi
Supplementary Figures 1 - 12, Supplementary Tables 1-5 from BLEACH&amp;STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
2023cited by 0position: contributordoi
Supplementary Figures 1 - 12, Supplementary Tables 1-5 from BLEACH&amp;STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
2023cited by 0position: contributordoi
Supplementary Figures 1 - 12, Supplementary Tables 1-5 from BLEACH&amp;STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration
2023cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 23 papers (2020–2026)Antonia Zapf · University of Lübeck12 papers (2022–2026)Bernd Löwe · ERN RARE-LIVER9 papers (2020–2026)Karl Wegscheider · Universität Hamburg6 papers (2015–2024) · 6 papers (2022–2026)Friedrich Koehler · Humboldt-Universität zu Berlin4 papers (2018–2025)Kerstin Koehler · Humboldt-Universität zu Berlin4 papers (2018–2025)Paulus Kirchhof · Amsterdam University Medical Centers4 papers (2020–2022)Sebastian Winkler · Unfallkrankenhaus Berlin4 papers (2018–2025)Sebastian Spethmann · Humboldt-Universität zu Berlin3 papers (2019–2025)Stefan Störk · Universitätsklinikum Würzburg3 papers (2015–2025)Lorenz C. Hofbauer · Institute of Aging3 papers (2022–2022)Christian‐Alexander Behrendt · German Research Institute for Public Administration2 papers (2022–2022)Günter Breithardt · Universitäts-Herzzentrum Freiburg-Bad Krozingen2 papers (2021–2022)Sonja Ständer · 481492 papers (2022–2025)Michael Heuser · Adelphi Group (United Kingdom)2 papers (2015–2018) · 2 papers (2015–2018)Felicitas Thol · Temple University2 papers (2015–2018)Oliver Deckwart · Goethe University Frankfurt2 papers (2018–2019)Ansgar W. Lohse · Universität Hamburg2 papers (2015–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pathology and Forensic Medicine · Oncology →